Skip to main content
. 2020 Apr 21;29:0963689720919434. doi: 10.1177/0963689720919434

Fig. 2.

Fig. 2.

Cost comparison between cohorts according to CRS grade or infection. (A) Comparison of costs between patients with CRS grade 0–2 and CRS grade 3–5 (total cost, P < 0.001; drug cost, P < 0.001; transfusion, P = 0.001; room charge, P = 0.009; treatment cost, P = 0.002; nursing, P = 0.002; radiology examination, P < 0.001; lab test, P = 0.001; oxygen supply, P < 0.001; physician, P = 0.005; other, P = 0.001). (B) Comparison of costs between infected and noninfected patients (total cost, P = 0.013; drug cost, P = 0.020; transfusion, P = 0.012; room charge, P = 0.017; nursing, P = 0.048; lab test, P = 0.007; oxygen supply, P = 0.007; physician, P = 0.029). CRS: cytokine release syndrome.